Sanctuary Advisors LLC Invests $18.77 Million in CVS Health Corporation $CVS

Sanctuary Advisors LLC bought a new stake in CVS Health Corporation (NYSE:CVS) in the second quarter, HoldingsChannel.com reports. The firm bought 181,430 shares of the pharmacy operator’s stock, valued at approximately $18,769,000.

Several other large investors also recently bought and sold shares of the stock. BlackRock Inc. purchased a new position in shares of CVS Health in the 2nd quarter valued at about $12,747,462,000. Norges Bank acquired a new stake in CVS Health in the fourth quarter valued at approximately $1,666,265,000. Wellington Management Group LLP lifted its stake in CVS Health by 193.2% in the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock worth $1,473,270,000 after acquiring an additional 12,233,675 shares during the last quarter. Pzena Investment Management LLC acquired a new position in CVS Health during the 2nd quarter worth approximately $1,217,558,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of CVS Health in the 2nd quarter valued at approximately $932,454,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently commented on CVS. Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 5th. Barclays lifted their price target on CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Argus increased their price objective on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a report on Wednesday, August 19th. Robert W. Baird set a $107.00 target price on CVS Health in a research report on Thursday, August 6th. Finally, Wells Fargo & Company upped their price target on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Twenty-two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Stock Performance

Shares of CVS stock opened at $93.01 on Monday. The stock’s 50-day moving average is $102.02 and its two-hundred day moving average is $88.95. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The firm has a market cap of $118.96 billion, a price-to-earnings ratio of 24.61, a PEG ratio of 0.85 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. The business had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company’s revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.